NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

Dr Ray O’Connor takes a look at the latest clinical articles in the field of genetics, which has seen large-scale ...

Chocolate makers are racing to secure the future of cocoa amid climate threats and disease outbreaks. From lab-grown cocoa ...

The University of Cincinnati Cancer Center's Annabelle Anandappa, MD, has received the ASCO Conquer Cancer Women Leaders in ...

As South Africa grapples with the implications of genome editing, the ethical debate intensifies. What does the future hold ...

Teen-agers with progeria have effectively aged eight or nine decades. A cure could help change millions of lives—and shed ...

Unlike conventional drug discovery pipelines—slow, expensive, and prone to failure—biological AI platforms like PROTEUS promise to speed up and personalize medicine on a scale we’ve never seen. But ...

A study published in the science methodology journal Nature Methods on July 10 by a team of scientists from Tianjin ...

A joint research team led by Chinese scientists, including researchers from South Korea, Japan, and the U.S., has successfully transplanted genetically modified pig lungs into a brain-dead patient for ...

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle cell, while also proving beyond doubt that chemical tags on DNA—often ...